American company Lilly announced the successful completion of trials of the drug tirzepatide for weight loss.
About 2, 5 volunteers who are overweight but not diabetic. The use of tirzepatide resulted in a reduction in body weight of almost a quarter (22.5%) at 72 weeks after the start of the course.
Participants lost from 16 kg (low dose of 5 mg) to 24 kg (high dose of 15 mg) weight.
The drug belongs to a variety of natural hormones that reduce appetite. The drug has shown better results than the competition and could turn a revolution and revolutionize the war on obesity.
Follow us on Telegram